Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.
Hi Tobriand. My view is not a strategic one but lends itself more from a moral and ethical standpoint. I invested in Feedback initially through finding out about Balaji Ganeshan at Sussex University. If this Textrad software has an ability to identify a range of deadly diseases at an early stage, thereby saving lives (or by extending them) then availability to use is key. In the same way that we have post code lottery for some health services an exclusive deal would act as a barrier to its use for many. We are led to believe that it's valued globally in research environments and CE certification will lead to similar values in clinical environments. What are your thoughts?
AR talked about installing Texrad lung as an add on to machines provided by largest CT scanner (hardware manufacturers) providers globally. These are Fujifilm,GE Healthcare, Siemens, Phillips,Toshiba and Hitachi. Global sales of medical imaging equipment by these companies was $32billion in 2016. Fantastic that such huge organisations are engaging with Feedback plc, with about 8 employees and market cap of �5million.
A research report by Visiongain on global CT markets forecasts global CT revenues at 5.3 billion$ for 2017 with predicted annual growth over next 10 years of 6% per annum.
AR talked about hardware manufacturers and their machines globally, not just one then! Looking excellent and BETA testing in clinical field with global organisations leading to pay per view, licencing and undoubtedly huge sales with 75%+ profit margins ( standard for tech software). No wonder Chairman is confident about 2018. How many scans globally? Don't know but 4 million+ in UK alone.
Hi everyone. Interview yesterday with AR very positive and interesting to hear him talk about new business model for Texrad lung, acquisition, licensing and per scan revenues. Looking at CT scan numbers I put up yesterday it's going to be enormous when revenues start flowing next year. Still can't believe market not cottoned on. Should be 10x where we are now.
NHS England Diagnostic Imaging Dataset statistics state in 12 months period ended January 2017 there were 4.6 million CT scans carried out. These figures are for England only but extrapolated globally gives some some idea of the vast numbers and sums involved. A CT scan costs around �500 each and PET scan up to �1000. It's a multi billion business globally and Texrad is acknowledged to be a leader in the medical imaging field.
Afternoon everyone. The sales from the CE marked Texrad lung result from RNS statements in last 12 months namely, 1. Letter of intent with leading global medical imaging company to make Texrad lung available worldwide on their imaging platforms and 2. Agreement with Alliance Medical to integrate Texrad lung onto scanners in UK hospitals. Alliance have a long term contract with NHS to provide scanner facility. The Texrad software saves time for radiologists analysis, provides more information and data about existing tumours and offers improved diagnosis and prognosis for patient treatment and care. It's potentially able to save NHS millions in CT and PET scanning costs and yes it's huge.
Thanks Ironfish. Looks as though progress being made to reduce overhang. The 3 million sell on market by TB a few weeks ago had a detrimental effect and maybe common sense kicked in for all parties. The CE announcement will have enabled sale in an orderly way. Thanks again for your insight.
London Stock Exchange marking all trades as "off book". Mean anything?
I agree Botak. This is clearly being managed by mm's however. The bid/ask spread has been tiny for months and is more akin to a much larger and liquid company. We are on the outside but not for long me thinks.
Morning mate! Arranged transfer of shares between seller and buyer? It's been in restricted range for a long time now.
1.3 million popped up this morning. Jimbob called a background buyer, he might be right.
Afternoon everyone. Well that was a better day, small steps, acorns and all that. Good to see decent volume again and Mr Cranston having confidence to go over 3%. All helps promote improvement in sentiment which as we know is key on Aim. Interesting to see it being sustained and built upon, company promoting recent transformational news would be helpful.
Someone shares my view!!
Morning Jolli. Something very unusual about the market in this stock for a few months now. The news whilst delayed continues to be great and increases validation of the company going forward. Alan Green of Brand Communications quoted a realistic value of �50 million+ some time ago but market won't have it. I don't understand the vagaries of shorting stocks but there is clearly something going on which isn't benefiting an appropriate valuation for this company. I have been here for three years now and am sure clinicians want to use Texrad, the revenues when this happens will be mind boggling but until the sentiment for the stock turns we are trading in this fairly narrow range.
Another positive piece of news. 18 papers being presented at RNSA, global acknowledgement of Texrad product, installed and used in 40 leading research centres globally, CE Mark achieved for Texrad lung and agreements to use across NHS England for CT scans, letter of intent with large global scanner manufacturer, now revenue earning etc, etc...... Market will recognise value at some stage, it's huge.
Had an exchange with Alan today. He agrees yesterday announcement is great news and paves the way for rollout of other CE marked products. He also agrees an overhang in shares has weighed on the price. He is ignoring short term trends and looking at the bigger picture which is Feedbacks ability to now press on with other CE marked applications. Probably reflects our own views but nevertheless good to hear from someone close to company.
Afternoon all. Disappointing isn't it? Personally I would like to see some PR visibility 're yesterday's great achievement 're CE Mark. The fund raising earlier in year included an element for marketing so let's get some positive news widely promoted. It appears that one shareholder has undue control over progress and the sooner he finishes then better for company going forward. It surprises me that given the magnitude of the CE announcement an institution hasn't secured a decent percentage of the company off market from TB.
Thanks for your observation Jimbob. You invested or an interested watcher?
That's a cracker El, absolutely hilarious!!